Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data.

Shiao Li Oei, Anja Thronicke, Gerrit Grieb, Friedemann Schad, Jessica Groß
Author Information
  1. Shiao Li Oei: Research Institut Havelhöhe gGmbH at, Hospital Gemeinschaftskrankenhaus Havelhöhe, Kladower Damm 221, 14089, Berlin, Germany. shiaoli.oei@havelhoehe.de. ORCID
  2. Anja Thronicke: Research Institut Havelhöhe gGmbH at, Hospital Gemeinschaftskrankenhaus Havelhöhe, Kladower Damm 221, 14089, Berlin, Germany. ORCID
  3. Gerrit Grieb: Department of Plastic Surgery and Hand Surgery, Hospital Gemeinschaftskrankenhaus Havelhöhe, Kladower Damm 221, 14089, Berlin, Germany.
  4. Friedemann Schad: Research Institut Havelhöhe gGmbH at, Hospital Gemeinschaftskrankenhaus Havelhöhe, Kladower Damm 221, 14089, Berlin, Germany. ORCID
  5. Jessica Groß: Breast Cancer Centre, Hospital Gemeinschaftskrankenhaus Havelhöhe, Kladower Damm 221, 14089, Berlin, Germany.

Abstract

BACKGROUND: Due to advances in the fight against breast cancer, aesthetic aspects and the prevention of breast deformities are playing an important role in surgical procedures. Currently the main form of breast cancer surgery is breast-conserving surgery (BCS), and even if mastectomy (MAS) is required, oncoplastic surgery and reconstruction options can improve outcomes, including health-related quality of life (QoL) of cancer patients. The purpose of this study was to assess whether surgery options induce different outcomes in self-reported QoL in guide-line treated breast cancer patients of the Network Oncology (NO).
METHODS: This prospective Real-World-Data (RWD) study was conducted using data from the NO-clinical registry. QoL was assessed by evaluation of the European Organization of Research and Treatment Health-Related Quality of Life Core Questionnaire scale (EORTC QLQ-C30). Association factors between type of surgery options, without or with immediate breast reconstructions the EORTC QLQ-C30-scales at baseline after surgery, 6, 12, and 24 months later were analyzed with adjusted multivariate regression analysis, considering age, cancer stage, and treatment regimens, using software R.
RESULTS: A total of 623 primary breast cancer patients (all tumor stages, median age 58 (ICR: 50-68) diagnosed and guide-line treated between 2013 and 2021), 524 BCS and 99 MAS, 24 of whom received immediate breast reconstruction (MBR), were eligible for analyses. Compared with BCS patients, MBR patients self-reported considerably lower global health, physical and social functioning, and higher burden of pain and financial difficulties at baseline. In later follow-up surveys, functional scales increased and symptoms decreased in all patients, and the differences between MAS and BCS equalized. Longitudinal analyses after 24 months were obtained from 258 patients and revealed that compared to 224 BCS, the 34 MAS patients reported increased social functioning (p = 0.04).
CONCLUSIONS: At 24 months after MAS, breast cancer patients' QoL improved compared with BCS, although impairments in QoL were reported immediately after MAS. A growing expertise in surgical procedures as well as supportive care is critical to optimizing patients' well-being. These findings may be considered when counseling breast cancer patients pre- and post-surgery.
TRIAL REGISTRATION NUMBER: DRKS00013335 on 27/11/2017 retrospectively registered.

Keywords

Associated Data

DRKS | DRKS00013335

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492 . [DOI: 10.3322/caac.21492]
  2. Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, et al. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst. 2004;96(5):376–87. [DOI: 10.1093/jnci/djh060]
  3. Hurtz HJ, Tesch H, Gohler T, Hutzschenreuter U, Harde J, Kruggel L, et al. Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project. Breast Cancer Res Treat. 2017;165(3):721–31. https://doi.org/10.1007/s10549-017-4365-7 . [DOI: 10.1007/s10549-017-4365-7]
  4. Jonczyk MM, Jean J, Graham R, Chatterjee A. Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis. Breast Cancer Res Treat. 2019;173(2):267–74. https://doi.org/10.1007/s10549-018-5018-1 . [DOI: 10.1007/s10549-018-5018-1]
  5. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32. https://doi.org/10.1056/NEJMoa020989 . [DOI: 10.1056/NEJMoa020989]
  6. de Haes JCJM, Curran D, Aaronson NK, Fentiman IS. Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial. Eur J Cancer. 2003;39(7):945–51. https://doi.org/10.1016/S0959-8049(03)00149-7 . [DOI: 10.1016/S0959-8049(03)00149-7]
  7. Johns N, Dixon JM. Should patients with early breast cancer still be offered the choice of breast conserving surgery or mastectomy? Eur J Surg Oncol. 2016;42(11):1636–41. https://doi.org/10.1016/j.ejso.2016.08.016 . [DOI: 10.1016/j.ejso.2016.08.016]
  8. Arndt V, Stegmaier C, Ziegler H, Brenner H. Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study. J Cancer Res Clin Oncol. 2008;134(12):1311–8. https://doi.org/10.1007/s00432-008-0418-y . [DOI: 10.1007/s00432-008-0418-y]
  9. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Hölzel D. Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J. 2004;10(3):223–31. https://doi.org/10.1111/j.1075-122X.2004.21323.x . [DOI: 10.1111/j.1075-122X.2004.21323.x]
  10. Rautalin M, Jahkola T, Roine RP. Surgery and health-related quality of life—a prospective follow up study on breast cancer patients in Finland. Eur J Surg Oncol. 2021;47(7):1581–7. https://doi.org/10.1016/j.ejso.2021.02.006 . [DOI: 10.1016/j.ejso.2021.02.006]
  11. Stolpner I, Heil J, Riedel F, Wallwiener M, Schäfgen B, Feißt M, et al. Long-term patient satisfaction and quality of life after breast-conserving therapy: a prospective study using the BREAST-Q. Ann Surg Oncol. 2021;28(13):8742–51. https://doi.org/10.1245/s10434-021-10377-4 . [DOI: 10.1245/s10434-021-10377-4]
  12. Słowik AJ, Jabłoński MJ, Michałowska-Kaczmarczyk AM, Jach R. Evaluation of quality of life in women with breast cancer, with particular emphasis on sexual satisfaction, future perspectives and body image, depending on the method of surgery. Psychiatr Pol. 2017;51(5):871–88. https://doi.org/10.12740/PP/OnlineFirst/63787 . [DOI: 10.12740/PP/OnlineFirst/63787]
  13. Ng ET, Ang RZ, Tran BX, Ho CS, Zhang Z, Tan W, et al. Comparing quality of life in breast cancer patients who underwent mastectomy versus breast-conserving surgery: a meta-analysis. Int J Environ Res Public Health. 2019;16(24):4970. https://doi.org/10.3390/ijerph16244970 . [DOI: 10.3390/ijerph16244970]
  14. Magnoni F, Alessandrini S, Alberti L, Polizzi A, Rotili A, Veronesi P, et al. Breast cancer surgery: new issues. Curr Oncol. 2021;28(5):4053–66. [DOI: 10.3390/curroncol28050344]
  15. Kaufman CS. Increasing role of oncoplastic surgery for breast cancer. Curr Oncol Rep. 2019;21(12):111. https://doi.org/10.1007/s11912-019-0860-9 . [DOI: 10.1007/s11912-019-0860-9]
  16. Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC. Neoadjuvant chemotherapy use in breast cancer is greatest in excellent responders: triple-negative and HER2+ subtypes. Ann Surg Oncol. 2018;25(8):2241–8. https://doi.org/10.1245/s10434-018-6531-5 . [DOI: 10.1245/s10434-018-6531-5]
  17. Heil J, Kuerer HM, Pfob A, Rauch G, Sinn HP, Golatta M, et al. Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges. Ann Oncol. 2020;31(1):61–71. https://doi.org/10.1016/j.annonc.2019.10.012 . [DOI: 10.1016/j.annonc.2019.10.012]
  18. Cordova LZ, Hunter-Smith DJ, Rozen WM. Patient reported outcome measures (PROMs) following mastectomy with breast reconstruction or without reconstruction: a systematic review. Gland Surg. 2019;8(4):441–51. [DOI: 10.21037/gs.2019.07.02]
  19. Schad F, Axtner J, Happe A, Breitkreuz T, Paxino C, Gutsch J, et al. Network Oncology (NO)—a clinical cancer register for health services research and the evaluation of integrative therapeutic interventions in anthroposophic medicine. Forsch Komplementmed. 2013;20(5):353–60. https://doi.org/10.1159/000356204 . [DOI: 10.1159/000356204]
  20. Schad F, Thronicke A, Merkle A, Steele ML, Kroz M, Herbstreit C, et al. Implementation of an integrative oncological concept in the daily care of a German certified breast cancer center. Complement Med Res. 2018;25(2):85–91. https://doi.org/10.1159/000478655 . [DOI: 10.1159/000478655]
  21. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76. [DOI: 10.1093/jnci/85.5.365]
  22. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. The EORTC QLQ-C30 Scoring Manual. 3rd ed. Brussels: EORTC; 2001.
  23. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10): e297. https://doi.org/10.1371/journal.pmed.0040297 . [DOI: 10.1371/journal.pmed.0040297]
  24. Scott NW, Fayers PM, Aaronson NK, Bottomley A, E. Q. o. L. Group. EORTC-QLQ-C30 reference values. https://www.eortc.org/app/uploads/sites/2/2018/02/reference_values_manual2008.pdf (2008).
  25. Lebovic GS. Oncoplastic surgery: a creative approach to breast cancer management. Surg Oncol Clin N Am. 2010;19(3):567–80. https://doi.org/10.1016/j.soc.2010.04.003 . [DOI: 10.1016/j.soc.2010.04.003]
  26. Heneghan HM, Prichard RS, Lyons R, Regan PJ, Kelly JL, Malone C, et al. Quality of life after immediate breast reconstruction and skin-sparing mastectomy - a comparison with patients undergoing breast conserving surgery. Eur J Surg Oncol. 2011;37(11):937–43. https://doi.org/10.1016/j.ejso.2011.08.126 . [DOI: 10.1016/j.ejso.2011.08.126]
  27. Fang SY, Shu BC, Chang YJ. The effect of breast reconstruction surgery on body image among women after mastectomy: a meta-analysis. Breast Cancer Res Treat. 2013;137(1):13–21. https://doi.org/10.1007/s10549-012-2349-1 . [DOI: 10.1007/s10549-012-2349-1]
  28. Rautalin M, Färkkilä N, Sintonen H, Saarto T, Taari K, Jahkola T, et al. Health-related quality of life in different states of breast cancer—comparing different instruments. Acta Oncol. 2018;57(5):622–8. https://doi.org/10.1080/0284186x.2017.1400683 . [DOI: 10.1080/0284186x.2017.1400683]
  29. Saboonchi F, Petersson LM, Wennman-Larsen A, Alexanderson K, Vaez M. Trajectories of anxiety among women with breast cancer: a proxy for adjustment from acute to transitional survivorship. J Psychosoc Oncol. 2015;33(6):603–19. https://doi.org/10.1080/07347332.2015.1082165 . [DOI: 10.1080/07347332.2015.1082165]
  30. Zehra S, Doyle F, Barry M, Walsh S, Kell MR. Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis. Breast Cancer. 2020;27(4):534–66. https://doi.org/10.1007/s12282-020-01076-1 . [DOI: 10.1007/s12282-020-01076-1]
  31. Browne JP, Jeevan R, Gulliver-Clarke C, Pereira J, Caddy CM, van der Meulen JHP. The association between complications and quality of life after mastectomy and breast reconstruction for breast cancer. Cancer. 2017;123(18):3460–7. https://doi.org/10.1002/cncr.30788 . [DOI: 10.1002/cncr.30788]
  32. Rautalin M, Jahkola T, Roine RP. Breast reconstruction-prospective follow up on breast cancer patients’ health-related quality of life. World J Surg. 2022;46(4):836–44. https://doi.org/10.1007/s00268-021-06426-4 . [DOI: 10.1007/s00268-021-06426-4]
  33. Gilmour A, Cutress R, Gandhi A, Harcourt D, Little K, Mansell J, et al. Oncoplastic breast surgery: a guide to good practice. Eur J Surg Oncol. 2021;47(9):2272–85. https://doi.org/10.1016/j.ejso.2021.05.006 . [DOI: 10.1016/j.ejso.2021.05.006]
  34. Char S, Bloom JA, Erlichman Z, Jonczyk M, Chatterjee A, Guo L. How does oncoplastic surgery compare with standard partial mastectomy? A systematic review of patient-reported outcomes. Plast Reconstr Surg. 2022;150(5):950e–8e. https://doi.org/10.1097/prs.0000000000009616 . [DOI: 10.1097/prs.0000000000009616]
  35. Bonci EA, Anacleto JC, Cardoso MJ. Sometimes it is better to just make it simple. De-escalation of oncoplastic and reconstructive procedures. Breast. 2023;69:265–73. https://doi.org/10.1016/j.breast.2023.03.006 . [DOI: 10.1016/j.breast.2023.03.006]
  36. McNeely ML, Binkley JM, Pusic AL, Campbell KL, Gabram S, Soballe PW. A prospective model of care for breast cancer rehabilitation: postoperative and postreconstructive issues. Cancer. 2012;118(8 Suppl):2226–36. https://doi.org/10.1002/cncr.27468 . [DOI: 10.1002/cncr.27468]
  37. Tang X. The effect of multi-supportive nursing on the postoperative rehabilitation of breast cancer patients. Am J Transl Res. 2021;13(6):7327–34. [PMID: 34306501]
  38. Oei SL, Thronicke A, Matthes H, Schad F. Assessment of integrative non-pharmacological interventions and quality of life in breast cancer patients using real-world data. Breast Cancer. 2021;28(3):608–17. https://doi.org/10.1007/s12282-020-01193-x . [DOI: 10.1007/s12282-020-01193-x]

MeSH Term

Humans
Middle Aged
Female
Mastectomy
Breast Neoplasms
Mastectomy, Segmental
Quality of Life
Prospective Studies

Word Cloud

Created with Highcharts 10.0.0breastpatientscancersurgeryBCSMASQoLreconstructionoptionsqualitylifeusing24 monthssurgicalproceduresbreast-conservingmastectomyoutcomesstudyself-reportedguide-linetreateddataEORTCimmediatebaselinelaterageMBRanalysessocialfunctioningincreasedcomparedreportedpatients'BACKGROUND:DueadvancesfightaestheticaspectspreventiondeformitiesplayingimportantroleCurrentlymainformevenrequiredoncoplasticcanimproveincludinghealth-relatedpurposeassesswhetherinducedifferentNetworkOncologyNOMETHODS:prospectiveReal-World-DataRWDconductedNO-clinicalregistryassessedevaluationEuropeanOrganizationResearchTreatmentHealth-RelatedQualityLifeCoreQuestionnairescaleQLQ-C30AssociationfactorstypewithoutreconstructionsQLQ-C30-scales612analyzedadjustedmultivariateregressionanalysisconsideringstagetreatmentregimenssoftwareRRESULTS:total623primarytumorstagesmedian58ICR:50-68diagnosed201320215249924receivedeligibleComparedconsiderablylowerglobalhealthphysicalhigherburdenpainfinancialdifficultiesfollow-upsurveysfunctionalscalessymptomsdecreaseddifferencesequalizedLongitudinalobtained258revealed22434p = 004CONCLUSIONS:improvedalthoughimpairmentsimmediatelygrowingexpertisewellsupportivecarecriticaloptimizingwell-beingfindingsmayconsideredcounselingpre-post-surgeryTRIALREGISTRATIONNUMBER:DRKS0001333527/11/2017retrospectivelyregisteredEvaluationunderwentreal-worldBreast-conservingHealth-relatedMastectomy

Similar Articles

Cited By